Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing Weekly

AIFMD implementation, end of Madoff settlements are nearing: hedge fund news, week 51

Saturday, December 22, 2012

In the week-ending December 21, 2012, Barclays Capital reported it would spin out its $2bn West Coast unit to launch a distressed debt hedge fund called Cloverfield Capital; former Citi executive Joel Salomon is reportedly preparing a long/short hedge fund that will focus on financial institutions; and Aaron Smith, former executive at computer trading firm Superfund, launched Pecora Capital and is opening up the quant fund to external investors.

The RBC Hedge 250 index was up +0.28% in November (+4.63% YTD); The final number for the Greenwich Hedge Fund Index was 0.36% (+4.6% YTD); The Dow Jones Credit Suisse Hedge Fund Index finished up 0.64% (+6.10% YTD); The Scotiabank Canadian Hedge Fund Index returned -0.16% (-4.66% YTD); The Barclay CTA Index fell 0.39% (-1.45% YTD); The Newedge CTA Index was down 0.15% (-3% YTD); The Emanagers Total Index gained 0.3% (+4.14% YTD); And the HFRX Global Hedge Fund Index gained +0.75% through mid-December (3.35% YTD).

Troy A.M.’s Trojan Fund is up 4.2% YTD; Daniel Loeb’s Third Point is expected to earn $500m in profits after making a bet that Greece would not be forced to leave the euro zone; Philip Falcone’s Harbinger Group declined 27% to $7.50 last week, its biggest decline on record; Odey A.M.’s UK Absolute Return Fund returned 33% YTD; and Thames River reported that it had failed to meet performance targets when the firm was acquired by F&C. Hedge funds lost 16% through short selling strategies YTD, reported Citiwire.

The latest ‘Top 100 U.S. Equity Hedge Funds’ list reveals that the top hedge funds’ assets increased by nearly $43bn, or 8.13%, over Q3; Eurekahedge reported that hedge fund assets had reached $1.77tln in November, up by $5.99bn from a month ago; the latest SS&C GlobeOp Forward Redemption Indicator for December 2012 ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for